Seeking Alpha

Sarepta buys manufacturing facility

  • Sarepta Therapeutics (SRPT) acquires a 26-acre multifunctional manufacturing facility in Massachusetts for ~$25M. It will use the site to make investigational exon skipping therapies for Duchenne muscular dystrophy. The transaction is expected to close in July.
  • The cGMP-qualified facility was built in 1996 and upgraded in 2006. It will support ~40 techs and support staff.
Comments (1)
  • tipota
    , contributor
    Comments (2) | Send Message
    It is all over.
    22 May, 11:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: